CR9594A - Proceso de fabricacion para tigeciclina - Google Patents

Proceso de fabricacion para tigeciclina

Info

Publication number
CR9594A
CR9594A CR9594A CR9594A CR9594A CR 9594 A CR9594 A CR 9594A CR 9594 A CR9594 A CR 9594A CR 9594 A CR9594 A CR 9594A CR 9594 A CR9594 A CR 9594A
Authority
CR
Costa Rica
Prior art keywords
manufacturing process
tigecicline
controlling
manufacturing
tigecycline
Prior art date
Application number
CR9594A
Other languages
English (en)
Spanish (es)
Inventor
Gurmukh Channa
Dominic Ventura
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9594A publication Critical patent/CR9594A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
CR9594A 2005-06-16 2007-12-14 Proceso de fabricacion para tigeciclina CR9594A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69117305P 2005-06-16 2005-06-16

Publications (1)

Publication Number Publication Date
CR9594A true CR9594A (es) 2008-03-07

Family

ID=37111782

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9594A CR9594A (es) 2005-06-16 2007-12-14 Proceso de fabricacion para tigeciclina

Country Status (22)

Country Link
US (1) US7705168B2 (cg-RX-API-DMAC7.html)
EP (1) EP1898884A2 (cg-RX-API-DMAC7.html)
JP (3) JP2008543871A (cg-RX-API-DMAC7.html)
KR (1) KR20080024201A (cg-RX-API-DMAC7.html)
CN (1) CN101198315A (cg-RX-API-DMAC7.html)
AR (1) AR055336A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006261636A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612228A2 (cg-RX-API-DMAC7.html)
CA (1) CA2610909A1 (cg-RX-API-DMAC7.html)
CR (1) CR9594A (cg-RX-API-DMAC7.html)
EC (1) ECSP078005A (cg-RX-API-DMAC7.html)
GT (1) GT200600259A (cg-RX-API-DMAC7.html)
IL (1) IL187979A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007015960A (cg-RX-API-DMAC7.html)
NO (1) NO20076264L (cg-RX-API-DMAC7.html)
PA (1) PA8680201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20070072A1 (cg-RX-API-DMAC7.html)
RU (1) RU2007145595A (cg-RX-API-DMAC7.html)
SV (1) SV2007002575A (cg-RX-API-DMAC7.html)
TW (1) TW200716203A (cg-RX-API-DMAC7.html)
WO (1) WO2006138641A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710906B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007713A2 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Isolation of tetracycline derivatives
DK2016045T3 (en) * 2006-04-24 2015-02-02 Teva Pharma TIGECYCLIN CRYSTAL FORM AND PROCEDURES FOR PREPARING IT
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
MX2008009520A (es) * 2006-11-29 2009-02-26 Teva Pharma Formas cristalinas de tigeciclina y procesos de preparacion de ellas.
US20080234504A1 (en) * 2006-11-30 2008-09-25 Evgeny Tsiperman Processes for preparation of 9-haloacetamidominocyclines
EP2114865A1 (en) * 2007-03-01 2009-11-11 Teva Pharmaceutical Industries Ltd. Processes for purification of tigecycline
WO2009052152A2 (en) * 2007-10-16 2009-04-23 Wyeth Tigecycline and methods of preparing intermediates
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CA2751238A1 (en) 2009-03-12 2010-10-07 Wyeth Llc Nitration of tetracyclines
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
WO2014167575A2 (en) 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
IN2013MU01127A (cg-RX-API-DMAC7.html) 2013-03-26 2015-05-01 Astron Res Ltd
CN103202814A (zh) * 2013-04-23 2013-07-17 成都百裕科技制药有限公司 一种注射用替加环素的制备方法
CN105924367B (zh) * 2016-04-18 2017-12-29 镇江高海生物药业有限公司 多西环素一水物的有关物质及其分析检测方法
WO2019147755A1 (en) * 2018-01-26 2019-08-01 AL Pharma, Inc. Manufacturing and packaging of a sterile drug product
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN116531322A (zh) * 2023-06-27 2023-08-04 遂成药业股份有限公司 一种高稳定性呋塞米注射液及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026248A (en) * 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US6660267B1 (en) * 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US5675030A (en) 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
WO2003099217A2 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
KR20070069182A (ko) * 2004-10-28 2007-07-02 와이어쓰 티게시클린 및 디곡신의 공동투여
WO2006099258A1 (en) * 2005-03-14 2006-09-21 Wyeth Tigecycline compositions and methods of preparation
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina

Also Published As

Publication number Publication date
AR055336A1 (es) 2007-08-22
US20070026080A1 (en) 2007-02-01
RU2007145595A (ru) 2009-07-27
KR20080024201A (ko) 2008-03-17
PE20070072A1 (es) 2007-02-25
CN101198315A (zh) 2008-06-11
BRPI0612228A2 (pt) 2011-03-29
ZA200710906B (en) 2009-03-25
JP2008543871A (ja) 2008-12-04
WO2006138641A3 (en) 2007-05-18
MX2007015960A (es) 2008-03-06
ECSP078005A (es) 2008-01-23
JP2010024252A (ja) 2010-02-04
AU2006261636A1 (en) 2006-12-28
US7705168B2 (en) 2010-04-27
SV2007002575A (es) 2007-01-03
TW200716203A (en) 2007-05-01
EP1898884A2 (en) 2008-03-19
CA2610909A1 (en) 2006-12-28
PA8680201A1 (es) 2007-01-17
WO2006138641A2 (en) 2006-12-28
IL187979A0 (en) 2008-03-20
GT200600259A (es) 2007-05-08
NO20076264L (no) 2008-03-10
JP2009191083A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
CR9594A (es) Proceso de fabricacion para tigeciclina
CY1121744T1 (el) Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων
CY1115036T1 (el) Μεθοδος για παραγωγη χειραλικων 8-(3-αμινο-πιπεριδιν-1-υλο)-ξανθινων
ECSP109882A (es) Derivados de 1-cianociclopropilo como inhibidores de la catepsina k
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
CR11161A (es) Procesos para la produccion de pirazoles
CY1115199T1 (el) Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση
PA8544901A1 (es) Derivados de oxazol
CR9569A (es) Modificaciones cristalinas de la piraclostrobina
AR077558A1 (es) Proceso para producir un producto de reposteria
CR11130A (es) Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados
ECSP088891A (es) Derivados bicíclicos como inhibidores de cetp
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
CR20140113A (es) Imidazopiridazinas sustituidas con amino
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
NO20080580L (no) Serumfritt kulturmedium for produksjon av redkombinante gonadotropiner
ATE485838T1 (de) Oligo- oder polyalkylenglycolgekoppelte thrombininhibitoren
UY34976A (es) Formas sólidas de un compuesto antiviral
CO6660435A2 (es) Una forma cristalina de clorhidrato de (r) -7- cloro-n- (quinuclidin -3-il)benzo[b] tiofeno-2- carboxamida monohodratado
GT200500330A (es) Derivados de quinolina e isoquinolina 5-sustituidos, un prodecimiento para su preparacion y su uso como inhibidores de la inflamacion
CU23820A3 (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y procedimiento de obtención
MX2022015151A (es) Procesos para preparar acido 3-(3-(3,5-dimetil-1h-pirazol-4-il)pro poxi)-4- 5-fluorobenzoico (ag-10), sus compuestos intermedios, y sales del mismo.
UY26847A1 (es) Derivados de la pirrolidina
UY27959A1 (es) Nuevos agonistas ppar alfa y ppar gama
CR8341A (es) Una composicion y metodo de tratamiento para condiciones urogenitales